TEC Brief: Recap of the Sept 2025 ACIP Meeting
The September 18-19, 2025 ACIP meeting addressed three vaccine topics: MMRV combination vaccine safety, hepatitis B birth dose timing, and COVID-19 vaccine recommendations. The newly appointed committee presented approximately 30 false or misleading claims during the two-day session.
Key topics and outcomes:
MMRV vaccine: Removed as an option for children under 4, eliminating VFC coverage
Hepatitis B: Tabled proposal to delay birth dose after medical liaison opposition
COVID-19: Shifted all age groups to shared clinical decision-making; prescription requirement narrowly defeated
This fact-check brief documents specific falsehoods presented by committee members, provides scientific corrections with citations, and notes departures from standard evidence evaluation processes. The analysis includes committee statements acknowledging that public concerns rather than new scientific data motivated their review of established vaccine policies.
The document serves as a resource for health communicators seeking accurate information to address vaccine-related misinformation emerging from the meeting.